1Khoo VS,Padhani AR,Tanner SF,et al.Comparison of MRI with CT for the radiotherapy planning of prostate cancer:a feasibility study.Br J Radiol,1999,72:590-597.
2Rasch C,Barillot I,Remeijer P,et al.Definition of the prostate in CT and MRI:a multi-olserver study.Int J Radiat Oncol Biol Phys,1999,43:57-66.
3Aoyama H,Shirato H,Nishioka T,et al.Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors.Int J Radiat Oncol Biol Phys,2001,50:821-827.
4Essig M,Debus J,Schlemmer HP,et al.Improved tumor contrast and delineation in the stereotactic radiotherapy planning of cerebral gliomas and metastases with contrast media-supported FLAIR imaging.Strahlenther Onkol,2000,176:84-94.
5Krempien RC,Daeuber S,Hensley FW,et al.Image fusion of CT and MRI data enables improved target volume definition in 3D-brachytherapy treatment planning.Brachytherapy,2003,2:164-171.
6Shimizu S,Shirato H,Aoyama H,et al.High-speed magnetic resonance imaging for four-dimensional treatment planning of conformal radiotherapy of moving body tumor.Int J Radiat Oncol Biol Phys,2000,48:471-474.
7Shimizu S,Shirato H,Xo B,et al.Three-dimensional movement of a liver tumor detected by high-speed magnetic resonance imaging.Radiother Oncol,1999,50:367-370.
8Schubert K,Wenz F,Krempien R,et al.Possibilities of an open magnetic resonance scanner integration in therapy simulation and three-dimensional radiotherapy planning.Strahlenther Onkol,1999,175:225-231.
9Okamoto Y,Kodama A,Kono M.Development and clinical application of MR simulation system for radiotherapy planning:with reference to intracranial and head and neck regions.Nippon Igaku Hoshasen Gakkai Zasshi,1997,57:203-210.
10Krempien RC,Schubert K,Zierhut D,et al.Open low-field magnetic resonance imaging in radiation therapy treatment planning.Int J Radiat Oncol Biol Phys,2002,53:1350-1360.
3DeGraef M,Karam R,Juhan V,et al.Hish signalsinthe uterine cervix on T2 weiglited MEI sequences[J].Eur Radiol,2005,15(1):118-126.
4Choi SH,Kim SH ,Choi HJ,et al . Preoperative magnetic resonance imaging staging of uterine cervical carcinoma,Results of prospective study[J]. J Comput Assist Fomogr,2004,28(5):620-627.
5Hricak H .Gatsonis C,Chi DS,et al.Role of imaging in pretreatment evaluation of early invasive cervical cancer:Results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183[J].J Clin Oncol,2005,23(56):9329-9357.
6Bipat S,GIas AS van der Velden J,et al.Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma:a systematic review[J]. Gynecol Oncol,2005,91(1): 59-66.
7Kim JK.Kim KA,Park BW.et al.Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastaticlymph nodes: Early experience[J].J Magn Reson Imaging,2008,28(3):714-719.
8Park SO,Kim JK,Kim JK,et al.gelative apparent diffusion coefficient:Determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer[J].J Magn Reson Imag,2009,29(2):585-390.
9Dma Y E Rouzier R,Ballester M,et al.Sentinel lymph node biopsy ingynaecological cancers:The importarice of micrometastases in cervical cancer[J]. Surg Oncol, 2008, 17(5): 227-255.
10Balega J,Van Trappen. PO.The sentinel node in gynaecological malignancies[J]. Cancer Imaging, 2006,6:7-15.
